TAME study
Study / Research
Targeting Aging with Metformin, a proposed human clinical trial to investigate Metformin's longevity benefits in non-diabetic individuals, inspired by epidemiological data.
Mentioned in 3 videos
Save the 3 videos on TAME study to your own pod.
Sign up free to keep building your knowledge base on TAME study as more episodes are added.
Videos Mentioning TAME study
#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Peter Attia MD
Targeting Aging with Metformin, a study led by Nir Barzilai to investigate if Metformin can prevent or delay age-related diseases in non-diabetic individuals.
#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP
Peter Attia MD
Targeting Aging with Metformin, a proposed human clinical trial to investigate Metformin's longevity benefits in non-diabetic individuals, inspired by epidemiological data.
#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?
Peter Attia MD
A study aiming to determine if Metformin can enhance longevity in non-diabetic, non-insulin resistant individuals.